Craig Wong-Pan
Stock Analyst at RBC Capital
(0.91)
# 3,989
Out of 4,978 analysts
333
Total ratings
47.7%
Success rate
-1.8%
Average return
Main Sectors:
Stocks Rated by Craig Wong-Pan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: CSL CSL Limited | Upgraded: Buy | $148.00 → $213.00 | $177.25 | +20.17% | 35 | Sep 15, 2026 | |
| ASX: NAN Nanosonics Limited | Upgraded: Buy | $3.00 → $3.75 | $2.94 | +27.55% | 20 | Sep 15, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Upgraded: Buy | $52.00 → $68.00 | $55.17 | +23.26% | 24 | Sep 15, 2026 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Upgraded: Buy | $39.00 → $52.00 | $44.32 | +17.33% | 6 | Sep 15, 2026 | |
| RMD ResMed | Upgraded: Buy | $244 → $262 | $228.25 | +14.79% | 38 | Sep 15, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Reiterated: Hold | $19.00 | $17.52 | +8.45% | 9 | Sep 14, 2026 | |
| ASX: REG Regis Healthcare Limited | Downgraded: Hold | $7.50 → $5.00 | $4.74 | +5.60% | 29 | Sep 3, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Reiterated: Buy | $2.60 → $3.20 | $2.33 | +37.34% | 24 | Aug 25, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Reiterated: Hold | $22.00 → $21.00 | $19.68 | +6.71% | 26 | Aug 20, 2026 | |
| ASX: HLS Healius Limited | Reiterated: Sell | $0.35 → $0.37 | $0.44 | -15.91% | 31 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $117.00 | $136.48 | -14.27% | 22 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2.35 → $2.40 | $2.89 | -16.96% | 21 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.13 → $0.12 | $0.10 | +20.00% | 23 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41.00 → $36.00 | $42.23 | -14.74% | 8 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $83 | $117.94 | -29.35% | 1 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.75 → $0.72 | $0.80 | -9.43% | 13 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $16.04 | $24.07 | n/a | 1 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31.60 | $12.22 | n/a | 1 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $6.57 | $21.01 | n/a | 1 | May 22, 2019 |
CSL Limited
Sep 15, 2026
Upgraded: Buy
Price Target: $148.00 → $213.00
Current: $177.25
Upside: +20.17%
Nanosonics Limited
Sep 15, 2026
Upgraded: Buy
Price Target: $3.00 → $3.75
Current: $2.94
Upside: +27.55%
Ramsay Health Care Limited
Sep 15, 2026
Upgraded: Buy
Price Target: $52.00 → $68.00
Current: $55.17
Upside: +23.26%
Fisher & Paykel Healthcare Corporation Limited
Sep 15, 2026
Upgraded: Buy
Price Target: $39.00 → $52.00
Current: $44.32
Upside: +17.33%
ResMed
Sep 15, 2026
Upgraded: Buy
Price Target: $244 → $262
Current: $228.25
Upside: +14.79%
Telix Pharmaceuticals Limited
Sep 14, 2026
Reiterated: Hold
Price Target: $19.00
Current: $17.52
Upside: +8.45%
Regis Healthcare Limited
Sep 3, 2026
Downgraded: Hold
Price Target: $7.50 → $5.00
Current: $4.74
Upside: +5.60%
Integral Diagnostics Limited
Aug 25, 2026
Reiterated: Buy
Price Target: $2.60 → $3.20
Current: $2.33
Upside: +37.34%
Sonic Healthcare Limited
Aug 20, 2026
Reiterated: Hold
Price Target: $22.00 → $21.00
Current: $19.68
Upside: +6.71%
Healius Limited
Aug 19, 2026
Reiterated: Sell
Price Target: $0.35 → $0.37
Current: $0.44
Upside: -15.91%
Aug 18, 2026
Reiterated: Hold
Price Target: $117.00
Current: $136.48
Upside: -14.27%
Aug 17, 2026
Reiterated: Hold
Price Target: $2.35 → $2.40
Current: $2.89
Upside: -16.96%
Jul 16, 2026
Reiterated: Hold
Price Target: $0.13 → $0.12
Current: $0.10
Upside: +20.00%
Jul 16, 2026
Reiterated: Buy
Price Target: $41.00 → $36.00
Current: $42.23
Upside: -14.74%
Jul 16, 2026
Downgraded: Hold
Price Target: $83
Current: $117.94
Upside: -29.35%
Jun 11, 2026
Reiterated: Hold
Price Target: $0.75 → $0.72
Current: $0.80
Upside: -9.43%
Oct 6, 2020
Reiterated: Sell
Price Target: $16.04
Current: $24.07
Upside: n/a
Oct 6, 2020
Reiterated: Buy
Price Target: $31.60
Current: $12.22
Upside: n/a
May 22, 2019
Downgraded: Sell
Price Target: $6.57
Current: $21.01
Upside: n/a